GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer

H. Yagi, K. Asanoma, T. Ohgami, A. Ichinoe, K. Sonoda, K. Kato

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

G-protein-coupled receptors (GPCRs) and their ligands function in the progression of human malignancies. G12 and G13, encoded by GNA12 and GNA13, respectively, are referred to as the GEP oncogene and are implicated in tumor progression. However, the molecular mechanisms by which G12/13 activation promotes cancer progression are not fully elucidated. Here, we demonstrate elevated expression of G12/13 in human ovarian cancer tissues. G12/13 activation did not promote cellular migration in the ovarian cancer cell lines examined. Rather, G12/13 activation promoted cell growth. We used a synthetic biology approach using chimeric G proteins and GPCRs activated solely by artificial ligands to selectively trigger signaling pathways downstream of specific G proteins. We found that G12/13 promotes proliferation of ovarian cancer cells by activating the transcriptional coactivator YAP, a critical component of the Hippo signaling pathway. Furthermore, we reveal that inhibition of YAP by short hairpin RNA or a specific inhibitor prevented the growth of ovarian cancer cells. Therefore, YAP may be a suitable therapeutic target in ovarian cancer.

Original languageEnglish
Pages (from-to)4471-4480
Number of pages10
JournalOncogene
Volume35
Issue number34
DOIs
Publication statusPublished - Aug 25 2016

Fingerprint

Oncogenes
Ovarian Neoplasms
Cell Proliferation
G-Protein-Coupled Receptors
GTP-Binding Proteins
Synthetic Biology
Ligands
Neoplasms
Growth Inhibitors
Small Interfering RNA
Cell Line
Growth
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer. / Yagi, H.; Asanoma, K.; Ohgami, T.; Ichinoe, A.; Sonoda, K.; Kato, K.

In: Oncogene, Vol. 35, No. 34, 25.08.2016, p. 4471-4480.

Research output: Contribution to journalArticle

@article{c200eb13d81447888f1a375f0d227652,
title = "GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer",
abstract = "G-protein-coupled receptors (GPCRs) and their ligands function in the progression of human malignancies. G12 and G13, encoded by GNA12 and GNA13, respectively, are referred to as the GEP oncogene and are implicated in tumor progression. However, the molecular mechanisms by which G12/13 activation promotes cancer progression are not fully elucidated. Here, we demonstrate elevated expression of G12/13 in human ovarian cancer tissues. G12/13 activation did not promote cellular migration in the ovarian cancer cell lines examined. Rather, G12/13 activation promoted cell growth. We used a synthetic biology approach using chimeric G proteins and GPCRs activated solely by artificial ligands to selectively trigger signaling pathways downstream of specific G proteins. We found that G12/13 promotes proliferation of ovarian cancer cells by activating the transcriptional coactivator YAP, a critical component of the Hippo signaling pathway. Furthermore, we reveal that inhibition of YAP by short hairpin RNA or a specific inhibitor prevented the growth of ovarian cancer cells. Therefore, YAP may be a suitable therapeutic target in ovarian cancer.",
author = "H. Yagi and K. Asanoma and T. Ohgami and A. Ichinoe and K. Sonoda and K. Kato",
year = "2016",
month = "8",
day = "25",
doi = "10.1038/onc.2015.505",
language = "English",
volume = "35",
pages = "4471--4480",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "34",

}

TY - JOUR

T1 - GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer

AU - Yagi, H.

AU - Asanoma, K.

AU - Ohgami, T.

AU - Ichinoe, A.

AU - Sonoda, K.

AU - Kato, K.

PY - 2016/8/25

Y1 - 2016/8/25

N2 - G-protein-coupled receptors (GPCRs) and their ligands function in the progression of human malignancies. G12 and G13, encoded by GNA12 and GNA13, respectively, are referred to as the GEP oncogene and are implicated in tumor progression. However, the molecular mechanisms by which G12/13 activation promotes cancer progression are not fully elucidated. Here, we demonstrate elevated expression of G12/13 in human ovarian cancer tissues. G12/13 activation did not promote cellular migration in the ovarian cancer cell lines examined. Rather, G12/13 activation promoted cell growth. We used a synthetic biology approach using chimeric G proteins and GPCRs activated solely by artificial ligands to selectively trigger signaling pathways downstream of specific G proteins. We found that G12/13 promotes proliferation of ovarian cancer cells by activating the transcriptional coactivator YAP, a critical component of the Hippo signaling pathway. Furthermore, we reveal that inhibition of YAP by short hairpin RNA or a specific inhibitor prevented the growth of ovarian cancer cells. Therefore, YAP may be a suitable therapeutic target in ovarian cancer.

AB - G-protein-coupled receptors (GPCRs) and their ligands function in the progression of human malignancies. G12 and G13, encoded by GNA12 and GNA13, respectively, are referred to as the GEP oncogene and are implicated in tumor progression. However, the molecular mechanisms by which G12/13 activation promotes cancer progression are not fully elucidated. Here, we demonstrate elevated expression of G12/13 in human ovarian cancer tissues. G12/13 activation did not promote cellular migration in the ovarian cancer cell lines examined. Rather, G12/13 activation promoted cell growth. We used a synthetic biology approach using chimeric G proteins and GPCRs activated solely by artificial ligands to selectively trigger signaling pathways downstream of specific G proteins. We found that G12/13 promotes proliferation of ovarian cancer cells by activating the transcriptional coactivator YAP, a critical component of the Hippo signaling pathway. Furthermore, we reveal that inhibition of YAP by short hairpin RNA or a specific inhibitor prevented the growth of ovarian cancer cells. Therefore, YAP may be a suitable therapeutic target in ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=84955575790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955575790&partnerID=8YFLogxK

U2 - 10.1038/onc.2015.505

DO - 10.1038/onc.2015.505

M3 - Article

C2 - 26804165

AN - SCOPUS:84955575790

VL - 35

SP - 4471

EP - 4480

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 34

ER -